RESUMEN
Campomelic dysplasia (CD) is a rare skeletal dysplasia caused by mutation in the SOX9 gene located on chromosome 17q24.3-q25.1, which regulates testis and chondrocyte development. Severe bowing of the long bones was seen at second-trimester scan. DNA analysis demonstrated a previously unreported de novo missense mutation in p.His165Pro. Ultrasound-based, molecular biology diagnosis led to early therapeutic termination of pregnancy. Histologic examination of the femoral epyphyseal growth plate confirmed scanty proliferation zone and maturation zone with degenerated chondrocytes.
Asunto(s)
Displasia Campomélica/genética , Mutación Missense , Factor de Transcripción SOX9/genética , Aborto Eugénico , Adulto , Sustitución de Aminoácidos , Displasia Campomélica/diagnóstico por imagen , Displasia Campomélica/embriología , Muestra de la Vellosidad Coriónica , Femenino , Humanos , Embarazo , Primer Trimestre del Embarazo , Ultrasonografía PrenatalRESUMEN
Sox9 is a direct transcriptional activator of cartilage-specific extracellular matrix genes and has essential roles in chondrogenesis. Mutations in or around the SOX9 gene cause campomelic dysplasia or Pierre Robin Sequence. However, Sox9-dependent transcriptional control in chondrogenesis remains largely unknown. Here we identify Wwp2 as a direct target of Sox9. Wwp2 interacts physically with Sox9 and is associated with Sox9 transcriptional activity via its nuclear translocation. A yeast two-hybrid screen using a cDNA library reveals that Wwp2 interacts with Med25, a component of the Mediator complex. The positive regulation of Sox9 transcriptional activity by Wwp2 is mediated by the binding between Sox9 and Med25. In zebrafish, morpholino-mediated knockdown of either wwp2 or med25 induces palatal malformation, which is comparable to that in sox9 mutants. These results provide evidence that the regulatory interaction between Sox9, Wwp2 and Med25 defines the Sox9 transcriptional mechanisms of chondrogenesis in the forming palate.
Asunto(s)
Complejo Mediador/deficiencia , Hueso Paladar/metabolismo , Proteínas Recombinantes/metabolismo , Factor de Transcripción SOX9/metabolismo , Ubiquitina-Proteína Ligasas/deficiencia , Animales , Displasia Campomélica/embriología , Displasia Campomélica/genética , Displasia Campomélica/metabolismo , Displasia Campomélica/patología , Cartílago/embriología , Cartílago/metabolismo , Cartílago/patología , Línea Celular , Condrogénesis/efectos de los fármacos , Condrogénesis/genética , Embrión de Mamíferos/metabolismo , Embrión de Mamíferos/patología , Embrión no Mamífero/metabolismo , Embrión no Mamífero/patología , Regulación de la Expresión Génica , Técnicas de Silenciamiento del Gen , Complejo Mediador/genética , Ratones , Ratones Transgénicos , Morfolinas/farmacología , Mutación , Hueso Paladar/efectos de los fármacos , Hueso Paladar/embriología , Hueso Paladar/patología , Unión Proteica , ARN Interferente Pequeño , Proteínas Recombinantes/genética , Factor de Transcripción SOX9/genética , Transcripción Genética , Activación Transcripcional , Transfección , Técnicas del Sistema de Dos Híbridos , Ubiquitina-Proteína Ligasas/genética , Pez CebraRESUMEN
Congenital abnormalities of the kidney and urinary tract are some of the most common defects detected in the unborn child. Kidney growth is controlled by the GDNF/RET signalling pathway, but the molecular events required for the activation of RET downstream targets are still poorly understood. Here we show that SOX9, a gene involved in campomelic dysplasia (CD) in humans, together with its close homologue SOX8, plays an essential role in RET signalling. Expression of SOX9 can be found from the earliest stages of renal development within the ureteric tip, the ureter mesenchyme and in a segment-specific manner during nephrogenesis. Using a tissue-specific knockout approach, we show that, in the ureteric tip, SOX8 and SOX9 are required for ureter branching, and double-knockout mutants exhibit severe kidney defects ranging from hypoplastic kidneys to renal agenesis. Further genetic analysis shows that SOX8/9 are required downstream of GDNF signalling for the activation of RET effector genes such as Sprouty1 and Etv5. At later stages of development, SOX9 is required to maintain ureteric tip identity and SOX9 ablation induces ectopic nephron formation. Taken together, our study shows that SOX9 acts at multiple steps during kidney organogenesis and identifies SOX8 and SOX9 as key factors within the RET signalling pathway. Our results also explain the aetiology of kidney hypoplasia found in a proportion of CD patients.
Asunto(s)
Displasia Campomélica/metabolismo , Células Epiteliales/metabolismo , Regulación del Desarrollo de la Expresión Génica , Riñón/embriología , Proteínas Proto-Oncogénicas c-ret/metabolismo , Factor de Transcripción SOX9/metabolismo , Transducción de Señal , Animales , Displasia Campomélica/embriología , Displasia Campomélica/genética , Células Cultivadas , Modelos Animales de Enfermedad , Femenino , Humanos , Riñón/metabolismo , Masculino , Ratones , Ratones Noqueados , Organogénesis , Proteínas Proto-Oncogénicas c-ret/genética , Factor de Transcripción SOX9/genética , Factores de Transcripción SOXE/genética , Factores de Transcripción SOXE/metabolismoRESUMEN
OBJECTIVES: Campomelic dysplasia is a rare congenital skeletal disorder characterized by bowing of the long bones and a variety of other skeletal and extraskeletal defects, many of which can now be identified prenatally using advanced ultrasound equipment. The disorder is caused by mutations in SRY-box 9 (SOX9), a gene that is abundantly expressed in chondrocytes as well as in other tissues. However, the correlation between genotype and phenotype is still unclear. We report five cases of prenatally detected campomelic dysplasia in which the diagnosis was confirmed by molecular analysis. METHODS: Ultrasound examinations were performed between 12 and 32 weeks. Standard fetal biometric measurements were obtained. Fetal sex was determined sonographically and confirmed by chromosomal analysis. Genomic DNA was obtained in four cases before termination of pregnancy from chorionic villi or amniocytes and in one case postnatally from peripheral blood. RESULTS: Skeletal dysplasia, most often limb shortening and bowed femora, was observed in one case in the first trimester, in three cases in the second trimester and in one case, presenting late for antenatal care, in the third trimester. Four of the pregnancies were terminated and one was carried to term. Postmortem/postnatal physical and radiographic examinations confirmed the presence of anomalies characteristic of campomelic dysplasia. A de novo mutation in the SOX9 gene was detected in all four cases that underwent termination. The father of the proband in the case that went to term was a carrier of a somatic mosaic mutation without clinical or radiographic signs of campomelic dysplasia. CONCLUSIONS: It is likely that the integrated expertise of ultrasonographers, obstetricians, pediatricians and clinical geneticists will markedly improve the likelihood of accurate prenatal clinical diagnoses of campomelic dysplasia. This will, in turn, encourage more specific molecular testing and facilitate comprehensive genetic counseling.